AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease

por Nakken, Sigrid, Eikrem, Øystein, Marti, Hans-Peter, Beisland, Christian, Bostad, Leif, Scherer, Andreas, Flatberg, Arnar, Beisvag, Vidar, Skandalou, Eleni, Furriol, Jessica, Strauss, Philipp
Publicado 2021

Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts

por Kipp, Anne, Marti, Hans-Peter, Babickova, Janka, Nakken, Sigrid, Leh, Sabine, Halden, Thea A. S., Jenssen, Trond, Vikse, Bjørn Egil, Åsberg, Anders, Spagnoli, Giulio, Furriol, Jessica
Publicado 2023

A multiomics disease progression signature of low-risk ccRCC

por Strauss, Philipp, Rivedal, Mariell, Scherer, Andreas, Eikrem, Øystein, Nakken, Sigrid, Beisland, Christian, Bostad, Leif, Flatberg, Arnar, Skandalou, Eleni, Beisvåg, Vidar, Furriol, Jessica, Marti, Hans-Peter
Publicado 2022